Distinguished in Chondrosarcoma

Jurgen P. Debus

Heidelberg, BW, DE 
Distinguished in Chondrosarcoma
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Jurgen Debus practices in Heidelberg, Germany. Debus is rated as a Distinguished expert by MediFind in the treatment of Chondrosarcoma. Their top areas of expertise are Adenoid Cystic Carcinoma, Glioma, Gliomatosis Cerebri, Mastectomy, and Prostatectomy.

Their clinical research consists of co-authoring 809 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Chondrosarcoma.

Locations

Heidelberg, BW, Germany
Other Locations
Munich, BY, Germany
Dresden, SN, Germany
Salem, BW, Germany
Berlin, BE, Germany
BG Trauma Center Ludwigshafen, Ludwig Guttmann Strasse 13, Ludwigshafen Am Rhein, RP 67071, Germany
Frankfurt Am Main, HE, Germany
Oberschleissheim, BY 85765, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Radiation, Drug
Study Drugs: Durvalumab, 5-Fluorouracil, Mitomycin C
Study Phase: Phase 2
Observational Study on Biomarkers in Head and Neck Cancer
Observational Study on Biomarkers in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Biological
Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux®
Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux®
Enrollment Status: Completed
Publish Date: May 25, 2022
Intervention Type: Radiation, Drug
Study Drug: Erbitux®
Study Phase: Phase 4
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
Enrollment Status: Completed
Publish Date: July 22, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
Randomized Phase II Study Evaluating a Carbon Ion Boost Applied After Combined Radiochemotherapy With Temozolomide Versus a Proton Boost After Radiochemotherapy With Temozolomide in Patients With Primary Glioblastoma
Randomized Phase II Study Evaluating a Carbon Ion Boost Applied After Combined Radiochemotherapy With Temozolomide Versus a Proton Boost After Radiochemotherapy With Temozolomide in Patients With Primary Glioblastoma
Enrollment Status: Completed
Publish Date: April 03, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
Clinical Phase I/II Trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients With Retroperitoneal Soft Tissue Sarcoma
Clinical Phase I/II Trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients With Retroperitoneal Soft Tissue Sarcoma
Enrollment Status: Completed
Publish Date: April 03, 2020
Intervention Type: Radiation
Study Phase: Phase 1/Phase 2
Phase I/II Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Phase I/II Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Enrollment Status: Completed
Publish Date: January 10, 2020
Intervention Type: Radiation
Study Phase: Phase 1/Phase 2
Evaluation of Inter- and Intrafractional Motion of Liver Tumors Using Interstitial Markers and Implantable Electro-magnetic Radiotransmitters in the Context of Image-guided Radiotherapy (IGRT) - the ESMERALDA Trial
Evaluation of Inter- and Intrafractional Motion of Liver Tumors Using Interstitial Markers and Implantable Electro-magnetic Radiotransmitters in the Context of Image-guided Radiotherapy (IGRT) - the ESMERALDA Trial
Enrollment Status: Withdrawn
Publish Date: May 17, 2018
Intervention Type: Behavioral
Study Phase: Not Applicable
Randomised Phase I/II Study to Evaluate Carbon Ion Radiotherapy Versus Fractionated Stereotactic Radiotherapy in Patients With Recurrent or Progressive Gliomas: The CINDERELLA Trial
Randomised Phase I/II Study to Evaluate Carbon Ion Radiotherapy Versus Fractionated Stereotactic Radiotherapy in Patients With Recurrent or Progressive Gliomas: The CINDERELLA Trial
Enrollment Status: Completed
Publish Date: May 17, 2018
Intervention Type: Radiation
Study Phase: Not Applicable
View 9 Less Clinical Trials

809 Total Publications

Prostate- and metastases-directed radiotherapy in de novo low-volume metastatic prostate cancer.
Prostate- and metastases-directed radiotherapy in de novo low-volume metastatic prostate cancer.
Journal: Clinical and translational radiation oncology
Published: August 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Debus's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 19 Advanced Conditions
View All 68 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile